GenSight Biologics S.A. (EPA:SIGHT)
0.2280
+0.0020 (0.88%)
Apr 1, 2025, 2:16 PM CET
GenSight Biologics Employees
GenSight Biologics had 16 employees as of December 31, 2023. The number of employees decreased by 29 or -64.44% compared to the previous year.
Employees
16
Change (1Y)
-29
Growth (1Y)
-64.44%
Revenue / Employee
€238,636
Profits / Employee
€1,272,818
Market Cap
28.97M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Sanofi | 82,878 |
EssilorLuxottica Société anonyme | 153,498 |
Sartorius Stedim Biotech | 9,901 |
bioMérieux | 13,982 |
Eurofins Scientific SE | 62,696 |
Ipsen | 5,358 |
Virbac | 5,459 |
emeis Société anonyme | 77,954 |
GenSight Biologics News
- 12 days ago - GenSight Biologics Confirms Definitive Full-Year 2024 Consolidated Financial Results Are in Line with Estimates - Business Wire
- 15 days ago - GenSight Biologics Announces LUMEVOQ® Scientific Updates at NANOS 2025 - Business Wire
- 4 weeks ago - GenSight Biologics S.A. reports FY results - Seeking Alpha
- 4 weeks ago - GenSight Biologics Reports Estimated Full-Year 2024 Consolidated Financial Results - Business Wire
- 6 weeks ago - GenSight Biologics Announces Five-Year Efficacy and Safety Results for LUMEVOQ® Gene Therapy at the Conclusion of the REFLECT Study - Business Wire
- 2 months ago - GenSight Biologics Reports End-of-Year Cash Position and Provides Business Update - Business Wire
- 2 months ago - GenSight Biologics Announces Publication of 5-Year Outcomes for Patients Treated Unilaterally with LUMEVOQ® Gene Therapy - Business Wire
- 3 months ago - GenSight Biologics Provides Update on Regulatory Discussions and Financial Situation - Business Wire